Provista Diagnostics is the name of the testing company, and it is a subsidiary of Todos Medical. In their latest press release, Provista indicated that they have the capability to do up to 20,000 PCR tests daily which equates to $2 million in sales daily or $60 million monthly. With respect to the cPass Neutralizing Antibody test it appears that they can do up to $3.6 million in sales monthly. Investors need to keep in mind these estimates assume maximum utilization.
https://microcapdaily.com/top-covid-stocks-in...oi/132727/